Brian W. Gilbert, PharmD, MBA, FCCM, FNCS, BCCCP, and Tessa R. Cox, PharmD, BCCCP, are experts in emergency medicine and DKA management. They dive into their groundbreaking study on the early use of subcutaneous insulin in mild to moderate DKA, revealing no significant difference in hospital stays between early and later treatment. The duo also discusses updated diagnostic criteria, management strategies, and the potential benefits of long-acting insulin, emphasizing the need for enhanced care protocols in emergency settings.
